UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
To Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported) February 23, 2010
PSYCHEMEDICS
CORPORATION
(Exact
Name of Registrant As Specified In Its Charter)
Delaware
(State or
Other Jurisdiction of Incorporation)
|
1-13738
(Commission
File Number)
125
Nagog Park, Acton,
Massachusetts
01720
(Address
of Principal Executive
Offices)
(Zip Code)
|
|
58-1701987
(I.R.S.
Employer Identification No.)
|
|
|
(978)
206-8220
(Registrant’s
Telephone Number, Including Area Code)
N/A
(Former
name or former address, if changed since last report)
|
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions
(see
General Instructions A.2. below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM
2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On
February 23, 2010, Psychemedics Corporation issued a press release announcing
preliminary results for the fourth quarter of 2009. A copy of the press release
is attached hereto as Exhibit 99.1 and incorporated by reference
herein.
Limitation on
Incorporation by Reference. The information in this Form 8-K and the
Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933 or the Exchange Act,
regardless of any general incorporation language in such filing.
Cautionary Note
Regarding Forward-Looking Statements. Except for historical information
contained in the press release attached as an exhibit hereto, the press release
contains forward-looking statements which involve certain risks and
uncertainties that could cause actual results to differ materially from those
expressed or implied by these statements. Please refer to the cautionary note in
the press release regarding these forward-looking statements.
ITEM
9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d)
Exhibits
The
following exhibits are filed herewith:
99.1
Press Release dated February 23, 2010.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned
hereunto
duly
authorized.
|
Dated:
February 23, 2010
|
PSYCHEMEDICS
CORPORATION
|
|
|
By:
|
/s/ Raymond J. Ruddy
|
|
|
Raymond
J. Ruddy
|
|
|
Vice
President and Controller
|